Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Cardiol. Mar 26, 2012; 4(3): 77-83
Published online Mar 26, 2012. doi: 10.4330/wjc.v4.i3.77
Figure 1
Figure 1 Variations in the primary endpoint (A) and in secondary endpoints (B). AP: Neutraceutical consisting of berberine, policosanol and red yeast rice; HOMA: Homeostasis model assessment; FMD: Flow-mediated dilation.